Teva Pharmaceutical Industries Limited TEVA
Set alert
At close · Oct 30
After hours · Oct 30, 7:23 PM ET
- YTD
- +34.86%
- 1 year
- +110.13%
- Open
- 41.17
- Prev close
- 41.47
- Mkt cap
- 49.09B
- Vol
- 7.36M
- Avg vol
- 5.49M
- EPS
- 0.60
- P/E
- 70.15
- Div yield
- 0.00%
More statistics
- Low
- 41.22
- High
- 42.59
- Forward P/E
- 13.58
- Beta
- 0.82
- Short ratio
- 4.40
- Inst. own
- 29.68%
- Dividend
- 0.00
- Ex-div date
- Nov 27, 2017
- Earnings
- Nov 3, 2026
- 50-d avg
- 38.98
- 200-d avg
- 34.53
- 1y target
- 47.58
5D chart
Signals (117)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 3:55 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:35 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:30 PM | 1 day ago |
| SMA: Bearish | Oct 30, 3:25 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:05 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 3:05 PM | 1 day ago |
| RSI: Oversold | Oct 30, 2:50 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 2:30 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:10 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 2:05 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:00 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:40 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:35 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:25 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:10 PM | 1 day ago |
| SMA: Bearish | Oct 30, 11:30 AM | 1 day ago |
| SMA: Bullish | Oct 30, 11:25 AM | 1 day ago |
| SMA: Bearish | Oct 30, 11:20 AM | 1 day ago |
| SMA: Bearish | Oct 30, 11:10 AM | 1 day ago |
| SMA: Bullish | Oct 30, 11:05 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 10:30 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:25 AM | 1 day ago |
| SMA: Bullish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 30, 9:30 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 9:30 AM | 1 day ago |
| RSI: Overbought | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bearish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:25 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:20 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:10 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:40 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:35 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 2:20 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 1:30 PM | 2 days ago |
| RSI: Overbought | Oct 29, 1:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:00 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 12:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 2 days ago |
| SMA: Bullish | Oct 29, 11:15 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:55 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:55 AM | 2 days ago |
| RSI: Overbought | Oct 29, 10:10 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 9:30 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 2 days ago |
| MACD: Sell Signal | Oct 28, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:25 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:55 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 12:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:25 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 10:10 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:00 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 3 days ago |
| RSI: Oversold | Oct 28, 9:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 27, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:20 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:20 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:45 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:35 PM | 4 days ago |
| RSI: Overbought | Oct 27, 2:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:40 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 11:45 AM | 4 days ago |
| SMA: Bearish | Oct 27, 11:10 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 10:45 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 10:40 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 10:20 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:10 AM | 4 days ago |
| RSI: Overbought | Oct 27, 9:55 AM | 4 days ago |
| RSI: Overbought | Oct 27, 9:35 AM | 4 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:50 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:30 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:25 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:20 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:40 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:35 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 1:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 12:45 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 12:30 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:05 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:00 PM | 5 days ago |
| SMA: Bullish | Oct 26, 11:10 AM | 5 days ago |
| SMA: Bearish | Oct 26, 11:05 AM | 5 days ago |
| SMA: Bullish | Oct 26, 10:50 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:35 AM | 5 days ago |
News
23 hours ago seekingalpha.com
Teva: I Still See Upside After A Massive Rally
Teva Pharmaceutical Industries is undergoing a strategic transformation, pivoting from generics to innovative biopharmaceuticals, with a robust new product pipeline. FDA approval of WELTRUZA and…
1 day ago fool.com
Teva Stock Has More Than Doubled in a Year. Where Will It Be in 3 Years?
Teva's pivot from generic drugs to branded drugs has fueled an 100% surge for shares over the past year. Based on recent results and catalysts, don't rule out a continued, steady move towards higher…
2 days ago zacks.com
What Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q3 Earnings
Get a deeper insight into the potential performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and…
-
4 days ago benzinga.com
Teva Pharmaceuticals International GmbH Acquires BioXcel Therapeutics' Assets For $57.5M Upfront Payment
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that it has completed the acquisition of assets from BioXcel…
4 days ago globenewswire.com
Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline
Teva acquires worldwide rights to BXCL501, expanding its neuroscience pipeline with a potential at-home treatment for agitation currently under FDA review
6 days ago seekingalpha.com
Baron Health Care Fund Q3 2026 Top Contributors And Detractors
TMO's organic growth of 5% exceeded consensus by 200 basis points, and management raised full-year organic growth guidance/. MTD's local-currency sales grew 6%, exceeding prior guidance of 3%. TEVA…
-
1 week ago benzinga.com
Teva Pharma And Sanofi Report Duvakitug Maintained Efficacy Through 44 Weeks In Ulcerative Colitis And Crohn's Disease
In UC, duvakitug maintained high rates of clinical remission, clinical response, and endoscopic improvement at Week 44In CD, duvakitug maintained high rates of endoscopic response, clinical response,…
-
2 weeks ago benzinga.com
Barclays Maintains Overweight on Teva Pharmaceutical Indus, Raises Price Target to $47
Barclays analyst Glen Santangelo maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price target from $42 to $47.
3 weeks ago benzinga.com
FDA Approves Teva's New Once-Monthly Schizophrenia Injection
FDA approves Teva's Weltruza, a once-monthly injectable for adults with schizophrenia, eliminating the need for daily oral medication.
-
3 weeks ago benzinga.com
Teva Pharmaceuticals Receives FDA Approval Of WELTRUZA For Extended-Release Injectable Suspension For The Treatment Of Schizophrenia In Adults
WELTRUZA clinical trial results demonstrated improvement in symptoms (PANSS), significant reduction in illness severity (CGI-S), as well as improvement in personal and social functioning (PSP).1 In…
-
4 weeks ago benzinga.com
Teva Pharma Presents New Ecopipam Data Highlighting Potential Benefits For Pediatric Tourette Syndrome Patients At MDS 2026
Based on a post hoc analysis, a majority of participants (~70%) experienced clinically meaningful tic reduction within 8 weeks of starting ecopipamAn interim 18-month analysis of an ongoing…
-
4 weeks ago benzinga.com
Teva Pharma Says Journal Of Child Neurology Publishes Comprehensive Review Examining Dopamine Pathways In Tourette Syndrome And Therapeutic Potential Of Ecopipam For Treatment Of Pediatric Patients With Tourette Syndrome
The published review examines dopamine’s role in tic generation and how approved and investigational drugs may affect dopamine to reduce tics as well as synthesizes clinical trial evidence that…
1 month ago benzinga.com
This Toll Brothers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiated bullish coverage on Vita Coco, Toll Brothers, Civeo, Teva and Kura Oncology, with price targets of $70, $159, $42, $55 and $30.
-
1 month ago benzinga.com
TD Cowen Initiates Coverage On Teva Pharmaceutical Indus with Buy Rating, Announces Price Target of $55
TD Cowen initiates coverage on Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy rating and announces Price Target of $55.
2 months ago benzinga.com
Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President
Trump secures drug pricing deals with nine pharma companies as Kennedy reveals intense pressure from the President to deliver.
-
2 months ago benzinga.com
Trump Administration Reaches New Drug Pricing Agreement With Nine Pharma Firms
https://www.whitehouse.gov/fact-sheets/2026/08/fact-sheet-president-donald-j-trump-announces-deal-with-nine-additional-pharmaceutical-manufacturers-to-lower-drug-prices-for-americans/
2 months ago benzinga.com
Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug
Aurinia Pharmaceuticals shares rise after settling patent litigation with Teva, which can launch generic voclosporin no earlier than December 2036.
-
2 months ago benzinga.com
Aurinia Settles Teva Patent Litigation, Protecting Voclosporin Exclusivity In U.S. Until December 2036 And Affirming Validity Of Key Patents Through 2037
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) today announced that it and its subsidiary, Aurinia Pharma U.S., Inc., (collectively, "Aurinia") have entered into a settlement agreement with Teva…
3 months ago benzinga.com
Bill Ackman Says Next $1 Trillion Company Will Come From Israel – ‘Imagine if Silicon Valley Was a Country’
Bill Ackman is bullish on Israel. Here's why he thinks investors should watch the region.
-
4 months ago benzinga.com
FDA Broadens Access to Over-The-Counter Naloxone Nasal Spray for Opioid Overdose
https://www.fda.gov/news-events/press-announcements/fda-broadens-access-over-counter-naloxone-nasal-spray-opioid-overdose
4 months ago benzinga.com
10 Health Care Stocks Whale Activity In Today's Session
10 Health Care Stocks Whale Activity In Today's Session
-
6 months ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today's Session
10 Health Care Stocks With Whale Alerts In Today's Session
6 months ago benzinga.com
Earnings Scheduled For April 29, 2026
Earnings Scheduled For April 29, 2026
7 months ago benzinga.com
Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda
Axsome gains after securing global rights to balipodect from Takeda, advancing schizophrenia pipeline amid bullish analyst targets.
-
7 months ago benzinga.com
FDA Adverse Event Monitoring System Q4 2025 Flags Multiple Potential New Drug Safety Signals, Including Hypersensitivity, Hypogammaglobulinemia, Colitis, Aplastic Anemia And Rhabdomyolysis Under Evaluation
https://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/october-december-2025-new-safety-information-or-potential-signals-serious-risks-identified-fda
9 months ago benzinga.com
Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday?
Wall Street posted modest gains on Wednesday, while gold extended its relentless rally, shattering records above $5,300 an ounce ahead of the Federal Open Market Committee meeting.
-
9 months ago benzinga.com
Earnings Scheduled For January 28, 2026
Earnings Scheduled For January 28, 2026
12 months ago benzinga.com
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
12 months ago benzinga.com
Earnings Scheduled For November 5, 2025
Earnings Scheduled For November 5, 2025
1 year ago benzinga.com
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures
SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza III Ventures.
1 year ago benzinga.com
SciSparc And AutoMax Call Off Merger
SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation.
-
1 year ago benzinga.com
10 Health Care Stocks Whale Activity In Today's Session
10 Health Care Stocks Whale Activity In Today's Session
1 year ago benzinga.com
This Wayfair Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
This Wayfair Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
-
1 year ago benzinga.com
Earnings Scheduled For January 29, 2025
Earnings Scheduled For January 29, 2025
-
1 year ago benzinga.com
RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday
RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday
-
2 years ago benzinga.com
Earnings Scheduled For January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
-
2 years ago benzinga.com
Ituran Location and Control Posts Q3 Results, Joins Crown Castle, Shopify And Other Big Stocks Moving Higher On Monday
U.S. stocks traded mostly lower, with the Dow Jones falling around 50 points on Monday. Shares of Ituran Location and Control Ltd. (NASDAQ: ITRN) gained during Monday’s session after the company…
-
2 years ago benzinga.com
Earnings Scheduled For November 8, 2023
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
-
3 years ago benzinga.com
Earnings Scheduled For August 2, 2023
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.
-
3 years ago benzinga.com
Earnings Scheduled For May 10, 2023
Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
-
3 years ago benzinga.com
Earnings Scheduled For February 8, 2023
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is likely to report earnings for its fourth quarter. • Bunge (NYSE:BG) is projected to report quarterly earnings at $3.22 per share on…
-
3 years ago benzinga.com
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
-
4 years ago benzinga.com
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Gainers
-
4 years ago benzinga.com
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus…
-
4 years ago benzinga.com
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 550 companies achieved new lows for the year.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 166 stocks hit new 52-week lows.